Eric Topol

@erictopol · Twitter · 2026-09-10 14:08 UTC

Patients with refractory cancer seeking treatment with engineered T cells (CAR T) are going to China where the cost is considerably less China $150-300K US $550-800K https://www.wsj.com/health/healthcare/patients-are-flying-to-china-for-the-latest-cancer-treatment-528659c3?st=fGzGjF&reflink=desktopwebshare_permalink